{"id":"NCT00566228","sponsor":"Mayo Clinic","briefTitle":"Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma","officialTitle":"Randomized, Double-Blind Phase III Clinical Trial Comparing Outcomes of Immunologic Autograft Engineering Versus Standard Autograft Collection in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-12","primaryCompletion":"2015-01-15","completion":"2015-01-15","firstPosted":"2007-12-03","resultsPosted":"2018-07-09","lastUpdate":"2018-07-09"},"enrollment":122,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Lymphoma"],"interventions":[{"type":"PROCEDURE","name":"autologous hematopoietic stem cell transplantation","otherNames":[]},{"type":"PROCEDURE","name":"leukapheresis","otherNames":[]}],"arms":[{"label":"Immunologic autograft engineering","type":"EXPERIMENTAL"},{"label":"Standard autograft collection","type":"ACTIVE_COMPARATOR"}],"summary":"RATIONALE: It is not yet known which method of stem cell collection is best for patients undergoing an autologous stem cell transplant.\n\nPURPOSE: This randomized phase III trial is comparing two different methods of collecting stem cells in patients undergoing stem cell transplant for diffuse large cell lymphoma.","primaryOutcome":{"measure":"Median Progression-free Survival","timeFrame":"Date of infusion to disease progression, relapse, or death from any cause whichever came first, assessed up to 24 months post enrollment.","effectByArm":[{"arm":"Immunologic Autograft Engineering","deltaMin":null,"sd":null},{"arm":"Standard Autograft Collection","deltaMin":null,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.690"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26826432","30978434"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":57},"commonTop":["Bruising","Peripheral sensory neuropathy","Platelet count decreased","Hemoglobin decreased","Injection site reaction"]}}